Polyrizon Ltd. (PLRZ)
NasdaqCM: PLRZ
· Precio en tiempo real · USD
10.86
-0.12 (-1.09%)
Al cierre: Aug 17, 2026, 1:03 PM
Polyrizon Ltd. (PLRZ) Stock Price, Analysis & Data
-1.09% (1D)
| Precio de compra | 7.92 |
| Capitalización de mercado | 22.63M |
| Ingresos (TTM) | n/a |
| Beneficio neto (TTM) | -3.33M |
| Beta | n/a |
| EPS (TTM) | -4.9 |
| Ratio PER (TTM) | n/a |
| Adelante PE | n/a |
| P/B (TTM) | 0.83 |
| P/S (TTM) | n/a |
| Earnings Date | n/a |
| Precio de venta | 13.82 |
| Volumen | 53,514 |
| Volumen medio (20D) | 46,840 |
| Abierto | 10.98 |
| Anterior Cerrar | 10.98 |
| Rango del día | 10.60 - 11.27 |
| Rango de 52 semanas | 2.88 - 18.20 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de PLRZ
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza block...
Industria Biotechnology
Sector Healthcare
IPO Fecha Oct 29, 2024
Empleados 2
Bolsa de Valores NasdaqCM
Símbolo bursátil PLRZ
Sitio web https://www.polyrizon-biotech.com
Desempeño financiero
En 2025, los ingresos de Polyrizon fueron 0, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron -3.33M, un aumento de 115.86%.
Estados financieros
8 meses hace · Associated Press Finance
BC-Most Active StocksHIVE Digital Technologies Ltd. 15,939,276 3.3797